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ABSTRACT
Decellularization of skeletal muscle is a process that removes cellular components of
skeletal muscle tissue while leaving behind the intact extracellular matrix (ECM).
Skeletal muscle ECM is currently being studied as a biologic scaffold for repairing
volumetric muscle loss (VML) because the removal of cells greatly reduces the
antigenicity of the donor tissue. Decellularization usually relies on passive diffusion of
detergents, surfactants and/or osmotic solutions to strip cells from the ECM. However,
passive diffusion alone is usually not sufficient for complete removal of cells from the
interior of large pieces of skeletal muscle using detergents, such as sodium dodecyl
sulfate (SDS). The goal of this study was to develop a device that not only removes
cells by perfusion from the interior of skeletal muscle, but also monitors the progress of
decellularization in real-time. The device, based around a Raspberry Pi, is a standalone system that does not require a desktop computer or expensive software
packages. Different flow rates (0.1, 1.0 and 10 mL/hr) along with different
concentrations of SDS (0.2% and 1.0%) were tested. Decellularization progress was
monitored and logged to an online spreadsheet. The device was found to be capable of
decellularizing the medial gastrocnemius of a rat in under 10 hours. Complete
decellularization was validated using fluorescent imaging. Perfusion decellularized
muscle samples were found to have no significant differences in collagen or sulfated
glycosaminoglycan (sGAG) content when compared to samples that were decellularized
using current passive diffusion protocols. The ECM obtained through the use of this
device is currently being used for the repair of VML in a rat model.
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INTRODUCTION

The human body is capable of repairing mild to moderate skeletal muscle
damage. However, these innate repair mechanisms are not able to repair and
regenerate large scale volumetric muscle loss (VML)1. Advances in tissue engineering
have yielded researchers and physicians a number of treatment options for other
tissues such as bone and skin2-4. In contrast, very few options exist for skeletal muscle
repair, although a number of scaffold-based and cell-based strategies are currently
being developed3,5,6. Biologic and synthetic scaffolds have been produced to provide a
stable environment for cell proliferation and the production of contractile tissue in vitro
and in vivo. Corona et al. found that a combination of muscle derived cells on an
acellular scaffold provided the most functional recovery compared to an acellular
scaffold alone7.
Scaffolds that are designed for skeletal muscle tissue engineering are not unlike
scaffolds used for other applications in the body. They must promote the adhesion and
proliferation of cells and must provide the engineered tissue with properties similar to
native tissue. Scaffold integration with host vascular and nervous networks must take
place for successful regeneration of skeletal muscle6. Scaffold-based strategies
composed of a biologic or synthetic biomaterial which may or may not be seeded with
cells prior to implantation. Biologic scaffolds include acellular extracellular matrix
(ECM)7-14,which are derived through the process of decellularization.
Decellularization is a process which removes the cellular components from a
tissue leaving behind the intact ECM15. Decellularized tissue is promising as a biologic
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scaffold because it retains the biochemical and morphological structure of the native
ECM while having dramatically lower antigenicity than an allograft because it lacks
foreign cell antigens15. Decellularization of tissues and whole organs can be
accomplished through the use of chemical agents such as: surfactants, detergents or
osmotic solutions8,15. Decellularization has been used to produce whole organ scaffolds
for the heart16, liver17, lungs18 and kidneys19. Whole organ decellularization in many
cases has been achieved through the use of vascular perfusion16-19. The major inlets
and outlets (arteries and veins) and the capillary network of organs allow for perfusion
of the entire organ. Skeletal muscle tissue lacks the major arteries and veins that are
found in whole organs such as the kidneys, heart and liver. Therefore perfusion
decellularization of skeletal muscle will require the introduction of an inlet port into the
tissue. Scaffolds composed of decellularized muscle are unique because they retain the
parallel alignment of the native muscle from which they were obtained and pores for cell
attachment left by the previous cells9. Decellularized muscle lacks the antigenicity of an
allogenic transplant but requires the infiltration of host cells, innervation, and
revascularization with associated integration into the host vasculature to produce
functioning myofibers6,20.
One detergent that has been used extensively in decellularization is sodium
dodecyl sulfate(SDS). SDS is an anionic surfactant that removes cells by disrupting the
phospholipid bilayer of the cell membrane15. Once a cell is lysed, SDS denatures
proteins within the cells which allows for more complete removal of cellular
components15. SDS has been used to decellularize whole organs and tissues for use in
tissue engineering applications, including skeletal muscle11. In addition, SDS was used
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to successfully decellularize whole organs using a perfusion based method. Although
SDS has been shown to cause more ECM degradation than other detergents, studies
have also shown SDS to be more effective at removing DNA from decellularized
tissues8.
The device was designed because we found that whole sections of muscle took
a considerable amount of time compared to other decellularized tissues. Merritt et al.
discussed injecting muscles with SDS multiple times throughout the day in order to
increase the rate of decellularization10. The injections were time consuming and require
considerably more decellularization fluid. Our goal was to develop a device that could
constantly deliver SDS to a muscle to shorten the time needed to achieve complete
decellularization, while not negatively affecting the biochemical and morphological
properties of decellularized muscle. Using a syringe pump to deliver SDS at known flow
rates would enable us to compare flow rates and time to complete decellularization. In
order to quantify the time to decellularization, the device would also need to be capable
of real-time monitoring of decellularization progress.
The macroscopic characteristics of muscle and decellularized muscle were used
to design the monitoring component of this device. Muscle is opaque and pinkish red in
color while decellularized muscle is much more transparent and white in color.
Myoglobin, an oxygen-binding protein found within muscle cells, is responsible for the
pinkish red color seen in intact muscle. As cells are lysed by SDS, the myoglobin is
flushed out of the remaining ECM along with other intracellular molecules. As the tissue
approaches complete decellularization, the amount myoglobin and other molecules that
absorb light reaches a minimum. Once all cellular components are removed, the
3

macroscopic and optical properties of the decellularized muscle remain constant and
the tissue can be assumed to be decellularized. Characterization of the perfusion
decellularized muscle with fluorescent labelling was used to validate claims of complete
decellularization. Biochemical assays were performed to quantify and compare the ECM
produced by the device to ECM derived through current decellularization protocols.

METHODS

Spectral Properties of Skeletal Muscle
An absorbance spectral sweep was performed on rat (Sprague Dawley)
gastrocnemius muscle samples in order to characterize the optical properties of native
and decellularized skeletal muscle. The gastrocnemius muscle was selected based on
its past use in muscle regeneration animal studies; the anticipated area of application
for this device. All animals used in this study were previously sacrificed as part of an
unrelated study and stored at -20°C until required for testing. In preparation for testing,
gastrocnemius muscle samples were dissected, and from each whole muscle sample a
central core was harvested using a biopsy punch (diameter = 6mm) and trimmed to a
thickness of 4mm. Cylindrical muscle sample cores were loaded into 96 well plates (one
sample per well) and incubated in a 1% SDS solution for 24 and 48 hours at room
temperature following published protocols. Untreated muscle samples were maintained
as controls (n=3 / sample group). At the prescribed time points, a spectral sweep of
tissue sample absorbance was measured (400-900nm, step size = 5nm) with the aid of
a plate reader (Biotek Model, Winooski, VT). For comparison, the absorbance spectra of
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myoglobin, an abundant intracellular skeletal muscle protein, were also characterized
(0.1, 0.3, and 0.6% in phosphate buffered saline). Absorbance versus wavelength data
for all muscle and myoglobin samples were plotted and examined for the presence of
decellularization sensitive absorbance peaks

Device Design and Fabrication
The design goal was to combine continuous tissue perfusion and real time optical
monitoring into a single bench top decellularization device. The two primary
components of the device are the muscle perfusion units and optical detection collars
with integrated data collection hardware and software. The perfusion units, optical
monitoring collars, and data collection hardware are housed within and mounted onto a
custom fabricated two piece enclosure (Figure 1). The enclosure was designed to
accommodate four individual decellularization units each capable of accommodating a
single muscle tissue sample. The closure also isolates the optical monitoring collars
from ambient light. Each of the four modular perfusion units consists of a rigid acrylic
cylinder (ID = 10mm; length = 40mm) which form the translucent perfusion chamber.
The inlet and outlet of each chamber is enclosed by watertight ports fashioned with Leur
lock style fitting and fabricated in acrylic with the aid of a 3-D printer (Objet 30, Objet,
Israel). The inlet port incorporates a removable 26-ga stainless steel hypodermic needle
(length = 20 mm). The needle is used to deliver decellularization solution deep into the
interior of individual muscle samples (Figure 2). The flow of decellularization fluid into
each decellularization unit was controlled via a commerical syringe pump (Model 210,
Harvard Apparatus, Holliston, MA) capable of delivering fluid to all four chambers over a
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broad range of flow rates (0.1 to 10ml/hr) that would be evaluated during device
characterization. Waste decellularization solution is collected in a reservoir for disposal
or evaluation.
The optical collar was fitted with a single light emitting diode (LED) producing a
peak emmitance centered at 535nm. Peak LED wavelength selection was motivated by
the results of the previously described muscle optical property characterization. The
light output of the LED is directed across the diameter of the collar. Located opposite to
the LED emitter, is a light dependent resistor (LDR) detector. The LDR detector
converts light intensity in photons to resistance in ohms. The optical collar with
integrated LED and LDR can be positioned along the length of the decellularization unit.
During decellularization monitoring the collar is positioned over the muscle sample,
such that the muscle tissue impedes the light path from the LED emitter to the LDR
detector. Analog voltages collected from the LDR were converted to digital values using
a 16-bit analog-to-digital converter (ADC) (Adafruit, NYC, NY). A miniaturized single
board computer (Raspberry Pi Foundation, United Kingdom) was used to power the
LEDs and to control collection of the digitized LDR voltage signal from the ADC. Custom
designed software (Python) was created to collect the voltage data and log it to an
online spreadsheet. Optical data was collected from the LDR every five minutes. The
complete system, including syringe pump and flat screen monitor, occupies a 0.5m X
0.5m footprint, a space that is compatible with typical laboratory workbenches.
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Perfusion Decellularized Muscle Characterization
For all device characterization testing, medical gastrocnemius muscle tissue was
harvested from Sprague Dawley rats and stored at -80°C until needed for testing as
previously described. Prior to decellularization all muscles were thawed and rinsed
briefly in DI water to remove any superficial blood or loosely adhered tissue. Whole
muscle samples were loaded into perfusion chambers, one muscle per chamber, and
the position was adjusted until the needle tip was visually located at the mid-belly region
of the muscle. Based on static decellularization pilot testing and guided by published
methods, muscle samples were perfused using a 1% SDS solution for a duration of 24
hours at a flow rate of 1ml/hr. Samples (n=4/timepoint) were collected both midway
through and at the completion of the perfusion treatment. Untreated muscle samples
were maintained as controls.
To explore the influence of key perfusion parameters (flow rate and solution
concentration) on decellularization duration, medial gastrocnemius muscle samples
were perfused at flow rates of either 0.1, 1, and 10mL/hr using SDS solutions at
concentration of 0.2 and 1%. A total of 6 parameter combinations were explored (n= 4/
parameter condition). Throughout perfusion testing the optical properties of each
muscle was measured and digitally logged every 5 minutes. The time to sample
decellularization was recorded as the time at which sample optical properties were
unchanged (<0.1% difference from the previous recording) for five continuous recording
(25 minutes). Histological data will be used to validate that tissues are decellularized at
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this endpoint. For comparison, statically decellularized muscle samples were
maintained as controls.
To examine the relationship between muscle optical properties and histological
appearance, representative untreated control and perfusion treated samples were
embedded in tissue freezing media (Triangle Biomedical Sciences, Inc., Durham NC),
sectioned at 8µm with a cryostat, and mounted onto glass microscope slides. Perfused
treated samples were selected from either the endpoint on the To visualize intracellular
proteins, mounted sections were immunoreacted for the presence of myoglobin (αrat
myoglobin, rabbit IgG1, 500:1, Sigma, St. Lous MO) and actin (phalloidin, 40:1, Sigma,
St. Louis MO) followed by incubation with the appropriate fluorescently labeled
secondary antibodies (αIgG, 500:1, Invitrogen, Carlsbad, CA). Sections were
counterstained with the nuclear staining reagent DAPI, and then microscopically imaged
(Ci-L, Nikon, Troy, NY). Digital images were captured, stored, and examined for the
presence of intracellular proteins and nuclear remnants.
To determine whether perfusion decellularization influenced the retention of key
ECM molecules within treated muscle samples the sulfated glycosaminoglycans
(sGAG) content for control and perfusion samples was quantified using the procedure
detailed in Barbosa et al21. Briefly, decellularized muscle samples (control and
perfusion) were digested in a solution containing 50 µg/mL proteinase K in 100 mM
K2HPO4 at a pH of 8.0 at 55ºC for 16 hours. The samples were then centrifuged and
filtered to obtain an extract free of tissue fragments. A 1,9-dimethylmethylene blue
(DMMB) solution was added to produce an insoluble GAG-DMMB complex. The
solution was then centrifuged and the supernatant was removed and the GAG-DMMB
8

complex was dissolved with a decomplexation solution. The absorbance of the resulting
solution was read at 656 nm with the aid of a plate reader (BioTek, Winooski, VT).
The collagen content for the control and perfusion samples was quantified using
a hydroxyproline assay. A modified version of the procedure found in Edwards was
used to analyze collagen content22. Briefly, all tissue samples were hydrolyzed in 6N
HCl for 16-20 hours at 115ºC. After which, samples were cooled to RT and diluted 1:5 in
DI water. A buffer composed of citric acid monohydrate, glacial acetic acid, sodium
acetate, sodium hydroxide, 1-propanol and toluene was prepared according to
Edwards. Hydroxyproline was dissolved in 100mL of the buffer at this stage to produce
a hydroxyproline standard. Chloramine-T was dissolved in DI water and in addition to 1propanol, was added to the buffer. A second buffer composed of 4dimethylaminobenzaldehyde, 1-propanol, and perchloric acid was also prepared. A
standard dilution was prepared in a 96-well plate and 50 µL of each sample was added
in triplicate. 100 µL of each buffer was added to each well (samples and standards) and
the plate was read immediately at 570 nm with the aid of a plate reader (BioTek,
Winooksi, VT).

RESULTS

Spectral Characterization of Skeletal Muscle
The absorbance spectral sweep for myoglobin solutions show a decreasing
absorbance peak with lower concentrations of myoglobin (Figure 4A). The absorbance
peak is found between 480-550 nm in the 0.6% solution. The absorbance peak of the
9

0.3% myoglobin solution is 58% smaller than the 0.6% solution. The 0.1% solution has
an absorbance peak that is 85% smaller than the 0.6% myoglobin solution.
Decellularizing skeletal muscle in 96-well plates provided quantitative data on the
progress of decellularization in the form of absorbance spectra. A representative sample
of the absorbance spectra of rat skeletal muscle, partially decellularized muscle and
decellularized muscle is shown in Figure 4B. An absorbance peak appears around 520550 nm in the muscle sample, is present but less pronounced in PDM and absent in
decellularized muscle. The absorbance peak for the PDM is 37% smaller than the
absorbance peak of the untreated muscle. Although there appears to be a peak under
450 nm, the plate reader was unable to produce reliable absorbance data at such small
wavelengths.

Device Design and Fabrication
The device performed as designed and produced decellularized muscle samples
for multiple flow rates and SDS concentrations. Four decellularization chambers were
housed in the 3D printed box (Figure 3A). The Raspberry Pi microcomputer, ADC,
GPIO breakout board, and a custom PCB were all mounted to the 3D printed top
(Figure 3B). The complete assembly of the device was connected to the internet, an
LCD monitor, and a keyboard and then powered through the Raspberry Pi (Figure 3: C
& D). The Raspberry Pi with the ADC was sufficient for monitoring the voltage of the
LDR and the python program was able to reliably upload the data to a log file saved in
Google spreadsheets. The log file, which could be read in real-time or after the
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completion of decellularization, provided meaningful data on the decellularization
progress of four chambers simultaneously.

Perfusion Decellularized Muscle Characterization
The cryosectioned and stained native skeletal muscle tissue samples showed the
presence of myoglobin, actin and nuclear remnants (Figure 5:A & D) and myofiber
alignment (Figure 5A). Although nuclear remnants cannot be seen in the midpoint
decellularized muscle samples, myoglobin and intracellular actin can still be detected
(Figure 5:B & E). Endpoint decellularized muscle tissue displayed an absence of
myoglobin, intracellular actin, and nuclear remnants (Figure 5:C & F). Individual
myofibers can be seen in Figure 5:A & D, however, after partial decellularization the
intact myofibers are absent in Figures 5:B & E.
The voltage logs generated by the Python program (Figure 6) provide a
visualization of decellularization progress. Muscles were determined to be completely
decellularized when the previous 5 readings had less than 0.1% change. The control
sample was not included; After one week, the muscle was not completely
decellularized. At an SDS concentration of 0.2%, the hours to decellularization were
142.7 ± 7.7, 42.4 ± 3.0, 9.9 ± 1.2 for the flow rates of 0.1 mL/hr, 1.0 mL/hr, and 10 mL/hr
respectively. While at an SDS concentration of 1.0%, the hours to decellularization were
107.0 ± 6.5, 35.1 ± 2.5, 7.2 ± 1.0 for the flow rates of 0.1 mL/hr, 1.0 mL/hr, and 10 mL/hr
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respectively. Although SDS concentration did have a significant effect on time to
decellularization (Figure 7), the device flow rate had a much greater effect.
Perfusion decellularization did not significantly affect collagen or sGAG
concentration when compared to diffusion decellularized control samples. Regardless of
flow rate or SDS concentration, none of the samples had significant differences in either
collagen or sGAG from the control samples (Figure 8). All averages were within 10% of
the diffusion decellularized control samples and of each other. No trends were observed
with regard to flow rate or concentration.

DISCUSSION

This device was primarily developed to decellularize bulky pieces of skeletal
muscle which are to be used as a template for engineered ECM scaffolds that are being
created in our lab23. In order to speed up decellularization of bulk skeletal muscle,
Merritt et al. injected muscle with SDS several times10. We found that bulky skeletal
muscle, such as MGAS, were not decellularized after up to a week in SDS simply with
agitation and daily solution changes. The purpose of this device was to provide constant
injection of SDS into the muscle to increase the rate of decellularization and to reduce
the amount of man-hours needed for injecting and changing solutions. The placement of
the needle into the midbelly of the muscle had a great effect on the time to complete
decellularization and practice was required to achieve consistent positioning and
results. The time to complete decellularization was greatly decreased by forcing SDS
out from the inside of the muscle rather than simple diffusion of SDS from the outside of
the muscle.
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In addition to decreasing the time to decellularization, this device is also able to
monitor the progress of decellularization. The macroscopic characteristics of muscle
and decellularized muscle were used to design the monitoring component. Rat skeletal
muscle is opaque and pink-red in color while decellularized muscle is much more
transparent and white in color. By decellularizing muscle in a 96-well plate and obtaining
an absorbance spectral sweep, we were able to quantify the change from muscle to
acellular ECM. We observed a local absorbance peak in the 520-550nm range in
muscle that was not seen in the decellularized muscle and was much less prominent
but still visible in the partially decellularized muscle (Figure 4). Although the actual
absorbance value was dependent on the thickness of the tissue, the local peak was
present in all muscle samples and absent in all decellularized samples. An LED with a
wavelength of 535 nm was selected for the detection collar to take advantage of the
absorbance peak. The muscle would therefore absorb less light as decellularization
progressed. In turn, as more light was transmitted through the tissue, the voltage across
the LDR would decrease. When the tissue had been completely decellularized, the
voltage across the LDR changed very little from one reading to the next. When five
consecutive voltage readings had less than 0.1% change, the sample was considered
to be decellularized.

The concentrations of SDS used to test the decellularization device were 1%, as
is seen in many SDS decellularization protocols, and 0.2%. The lower concentration
was used as it is below the critical micelle concentration (CMC) for SDS, ~0.225%24.
The concentration of SDS had a significant effect on the time to decellularization but the
flow rate had a much larger effect (Figure 7). Although SDS-based protocols have been
13

found to cause significant deterioration of the ECM compared to other detergents and
decellularization protocols8,25,26, SDS was chosen for this device as it provided a simple
protocol and has been used in other perfusion based decellularization methods.
Collagen and sGAG were quantified for all the conditions to determine if perfusion
based decellularization had a deleterious effect on the acellular ECM. Any advantages
the perfusion device could provide would be for naught if the system produced
substandard scaffolds. The biochemical composition of the ECM from the perfused and
control samples did not differ significantly from one another (Figure 8).

The detection collar and associated hardware and software allowed us to monitor
in real-time the progress of the tissue from muscle to acellular ECM. The device was
originally tested using a desktop computer and National Instruments LabView software
to log the voltage data from the LDRs. While the device was fully functional and
performed as designed, the device neither required the computing power of the desktop
computer nor the robustness of the LabView software package. The Raspberry Pi
provides internet connectivity, a platform for programming in Python, and a set of GPIO
pins, all of which were used in this application and allowed the device to operate as a
stand-alone device. Once the device was set up and connected to the internet using an
Ethernet cord, the device did not need a monitor, mouse or keyboard as it could be
accessed using SSH protocol. In addition to starting via the command line, the python
program could be initiated and shutdown with an SSH client from any smartphone or
desktop computer with internet connectivity. Logging the voltage data every five minutes
was sufficient for analyzing decellularization progress without creating an extremely
large file.
14

This device is novel in its approach to decellularize skeletal muscle and to
monitor the progress of decellularization. However, there is not a widespread need for
the ECM processed by this device. Most regenerative medicine strategies for skeletal
muscle repair involve very thin (<3mm) acellular scaffolds, as host cells do not infiltrate
much further than that when used to repair skeletal muscle in vivo. Host cell infiltration
is dependent on angiogenesis within the implanted scaffold6. Even with established or
nascent vasculature in vitro, without immediate anastomosis with the host’s vasculature,
cells in the interior of a scaffold will not survive. Until progress is made toward
angiogenesis and/or revascularization of tissue constructs post-implantation, bulky
skeletal muscle ECM will not have a translational application.

Potential refinements to the device include controlling the syringe pump with the
Raspberry Pi, along with modifications to the enclosure to improve loading of muscles
into the chambers and to increase the number of chambers that can be housed. If the
production of acellular ECM needs to be increased, the device can be expanded. The
device was designed to be modular in that a single chamber could be used or up to four
chambers, using the current housing, could be run simultaneously. Although the number
of chambers is limited by the capacity of our current syringe pump, the Raspberry Pi
and ADC can accommodate eight analog voltage inputs. In addition, other
decellularization protocols could be adapted for use in this device. Another use for this
device could also be to recellularize acellular scaffolds by flowing media into the
midbelly of the scaffold. This would require a much faster flow rates, a peristaltic pump
instead of a syringe pump, and a separate reservoir for gas exchange within the media.
Additionally, the device would have to operate in an incubator under sterile conditions.
15

Preliminary trials have begun adapting other decellularization solutions and
protocols for use in this perfusion driven device. In addition, this device is currently
being operated to provide skeletal muscle ECM scaffolds which are being used to study
the repair of VML in a rat model. The perfusion derived skeletal muscle ECM is part of a
larger investigation into VML repair including comparisons to cell-derived ECM as a
biologic tissue repair scaffold.

FIGURES

A
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D

Figure 1: A-C Components of the decellularization chamber as drawn in SolidWorks and
printed on a 3-D Printer. A. Outlet port. B Inlet port. C Detection collar. D
Decellularization chamber as designed in SolidWorks, complete with Leur lock
connectors and 26 ga. needle.
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Figure 2: A. 26 ga. needle epoxyed into inlet port. B.
Inlet is connected to syringe pump and needle is
inserted in muscle. C. Chamber is filled with SDS and
outlet is connected to waste collector. D. Detector is
positioned around the muscle. (Photos by Benjamin
Kasukonis)
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D

Figure 3: A. Four decellularization chambers inserted in the lower portion of the device.
B. Top of the device with the Raspberry Pi, ADC, circuit board, and GPIO breakout C.
Complete assembly of the decellularization device. D. Inside view of the device. (Photos
by Benjamin Kasukonis
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Figure 4: A. Absorbance spectra for various concentrations of myoglobin. B.
Absorbance spectra for representative samples of muscle (M), partially decellularized
muscle (PDM), and decellularized muscle (DM).
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Figure 5: 8µm muscle(A,D), midpoint perfusion decellularized muscle(B,E), and
endpoint perfusion decellularized muscle(C,F) sections stained with phalloidin(red),
DAPI(blue), and immunostained for myoglobin(green). A-C Longitudinal sections. D-F
Transverse sections. (Images by Benjamin Kasukonis)
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Figure 6: Representitive voltage logs displaying decellularization progress from 0.2%
SDS perfused samples.
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Figure 7: Comparison of SDS concentrations and device flow rates. n=4 for all
conditions.
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A

B

Figure 8: A. Collagen content as measured by hydroxyproline assay. B. sGAG content
as measured by DMMB assay. n=4 for all groups.
22

REFERENCES

1. Borschel, G.H., Dennis, R.G., and Kuzon, W.M.J. Contractile Skeletal Muscle TissueEngineered on an Acellular Scaffold. Plastic and Reconstructive Surgery 113, 2004.
2. Bi, H., and Jin, Y. Current progress of skin tissue engineering: Seed cells,
bioscaffolds, and construction strategies. Burns and Trauma 1, 63, 2013.
3. Fisher, M.B., and Mauck, R.L. Tissue engineering and regenerative medicine: recent
innovations and the transition to translation. Tissue Engineering Part B: Reviews 19, 1,
2013.
4. Jayarama Reddy, V., Radhakrishnan, S., Ravichandran, R., Mukherjee, S.,
Balamurugan, R., Sundarrajan, S., and Ramakrishna, S. Nanofibrous structured
biomimetic strategies for skin tissue regeneration. Wound Repair and Regeneration 21,
1, 2013.
5. Juhas, M., Engelmayr, G.C.,Jr, Fontanella, A.N., Palmer, G.M., and Bursac, N.
Biomimetic engineered muscle with capacity for vascular integration and functional
maturation in vivo. Proceedings of the National Academy of Sciences of the United
States of America 111, 5508, 2014.
6. Turner, N.J., and Badylak, S.F. Regeneration of skeletal muscle. Cell and tissue
research 347, 759, 2012.
7. Corona, B.T., Ward, C.L., Baker, H.B., Walters, T.J., and Christ, G.J. Implantation of
in vitro tissue engineered muscle repair constructs and bladder acellular matrices
partially restore in vivo skeletal muscle function in a rat model of volumetric muscle loss
injury. Tissue Engineering Part A 20, 705, 2013.
8. Gillies, A.R., Smith, L.R., Lieber, R.L., and Varghese, S. Method for decellularizing
skeletal muscle without detergents or proteolytic enzymes. Tissue Engineering Part C:
Methods 17, 383, 2010.
9. Hinds, S., Bian, W., Dennis, R.G., and Bursac, N. The role of extracellular matrix
composition in structure and function of bioengineered skeletal muscle. Biomaterials 32,
3575, 2011.
10. Merritt, E.K., Cannon, M.V., Hammers, D.W., Le, L.N., Gokhale, R., Sarathy, A.,
Song, T.J., Tierney, M.T., Suggs, L.J., Walters, T.J., and Farrar, R.P. Repair of
traumatic skeletal muscle injury with bone-marrow-derived mesenchymal stem cells
seeded on extracellular matrix. Tissue Engineering.Part A 16, 2871, 2010.

23

11. Perniconi, B., Costa, A., Aulino, P., Teodori, L., Adamo, S., and Coletti, D. The promyogenic environment provided by whole organ scale acellular scaffolds from skeletal
muscle. Biomaterials 32, 7870, 2011.
12. Valentin, J.E., Turner, N.J., Gilbert, T.W., and Badylak, S.F. Functional skeletal
muscle formation with a biologic scaffold. Biomaterials 31, 7475, 2010.
13. Wang, L., Johnson, J.A., Chang, D.W., and Zhang, Q. Decellularized musculofascial
extracellular matrix for tissue engineering. Biomaterials 34, 2641, 2013.
14. Wolf, M.T., Daly, K.A., Reing, J.E., and Badylak, S.F. Biologic scaffold composed of
skeletal muscle extracellular matrix. Biomaterials 33, 2916, 2012.
15. Gilbert, T.W., Sellaro, T.L., and Badylak, S.F. Decellularization of tissues and
organs. Biomaterials 27, 3675, 2006.
16. Ott, H.C., Matthiesen, T.S., Goh, S., Black, L.D., Kren, S.M., Netoff, T.I., and Taylor,
D.A. Perfusion-decellularized matrix: using nature's platform to engineer a bioartificial
heart. Nature medicine 14, 213, 2008.
17. Uygun, B.E., Soto-Gutierrez, A., Yagi, H., Izamis, M., Guzzardi, M.A., Shulman, C.,
Milwid, J., Kobayashi, N., Tilles, A., and Berthiaume, F. Organ reengineering through
development of a transplantable recellularized liver graft using decellularized liver
matrix. Nature medicine 16, 814, 2010.
18. Ott, H.C., Clippinger, B., Conrad, C., Schuetz, C., Pomerantseva, I., Ikonomou, L.,
Kotton, D., and Vacanti, J.P. Regeneration and orthotopic transplantation of a
bioartificial lung. Nature medicine 16, 927, 2010.
19. Sullivan, D.C., Mirmalek-Sani, S., Deegan, D.B., Baptista, P.M., Aboushwareb, T.,
Atala, A., and Yoo, J.J. Decellularization methods of porcine kidneys for whole organ
engineering using a high-throughput system. Biomaterials 33, 7756, 2012.
20. Levenberg, S., Rouwkema, J., Macdonald, M., Garfein, E.S., Kohane, D.S.,
Darland, D.C., Marini, R., van Blitterswijk, C.A., Mulligan, R.C., and D'Amore, P.A.
Engineering vascularized skeletal muscle tissue. Nature biotechnology 23, 879, 2005.
21. Barbosa, I., Garcia, S., Barbier-Chassefiere, V., Caruelle, J.P., Martelly, I., and
Papy-Garcia, D. Improved and simple micro assay for sulfated glycosaminoglycans
quantification in biological extracts and its use in skin and muscle tissue studies.
Glycobiology 13, 647, 2003.
22. Edwards, C. Modified assay for determination of hydroxyproline in a tissue
hydrolyzate. Clinica chimica acta 104, 161, 1980.

24

23. Wolchok, J.C., and Tresco, P.A. The isolation of cell derived extracellular matrix
constructs using sacrificial open-cell foams. Biomaterials 31, 9595, 2010.
24. Dominguez, A., Fernandez, A., Gonzalez, N., Iglesias, E., and Montenegro, L.
Determination of Critical Micelle Concentration of Some Surfactants by Three
Techniques. Journal of chemical education 74, 1227, 1997.
25. Faulk, D.M., Carruthers, C.A., Warner, H.J., Kramer, C.R., Reing, J.E., Zhang, L.,
D'Amore, A., and Badylak, S.F. The effect of detergents on the basement membrane
complex of a biologic scaffold material. Acta biomaterialia 10, 183, 2014.
26. Keane, T.J., Londono, R., Turner, N.J., and Badylak, S.F. Consequences of
ineffective decellularization of biologic scaffolds on the host response. Biomaterials 33,
1771, 2012.

25

APPENDIX:
Python program
#!/usr/bin/python
import time, signal, sys, datetime, gspread
from Adafruit_ADS1x15 import ADS1x15
#Function from signal library that will end script (Ctrl+C)
def signal_handler(signal, frame):
print 'Session Ended'
sys.exit(0)
signal.signal(signal.SIGINT, signal_handler)

ADS1015 = 0x00
ADS1115 = 0x01

# 12-bit ADC
# 16-bit ADC

# Select the gain
# gain = 61
# +/- 6.144V
gain = 4096 # +/- 4.096V
# gain = 2048 # +/- 2.048V
# gain = 1024 # +/- 1.024V
# gain = 512
# +/- 0.512V
# gain = 256
# +/- 0.256V
# Select the
sps = 8
#
# sps = 16
# sps = 32
# sps = 64
# sps = 128
# sps = 250
# sps = 475
# sps = 860

sample rate
8 samples per second
# 16 samples per second
# 32 samples per second
# 64 samples per second
# 128 samples per second
# 250 samples per second
# 475 samples per second
# 860 samples per second

# Initialize the ADC using the default mode (use default I2C address)
adc = ADS1x15(ic=ADS1115)
#
#
#
#

Read voltage in single-ended mode using ADS1x15 library
volts = adc.readADCSingleEnded(channel, gain, sps) / 1000
Example: To read channel 3 in single-ended mode, +/- 1.024V, 860 sps use:
volts = adc.readADCSingleEnded(3, 1024, 860)

# Define the functions that will be used to query the ADC for voltage
def read1():
volts1 = adc.readADCSingleEnded(0, gain, sps) / 1000
return volts1
def read2():
volts2 = adc.readADCSingleEnded(1, gain, sps) / 1000
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return volts2
def read3():
volts3 = adc.readADCSingleEnded(2, gain, sps) / 1000
return volts3
def read4():
volts4 = adc.readADCSingleEnded(3, gain, sps) / 1000
return volts4
print 'Checking account...'
#Google account details (Redacted for publication)
email = '******************'
password = '*********'

#Attempt to log in to google account using supplied credentials
try:
gc = gspread.login(email,password)
except:
print('Login information invalid.')
sys.exit()
print 'Account valid.\n'
#Name of the spreadsheet to be appended
spreadsheet = 'Decell_Log'
#Open the spreadsheet
worksheet = gc.open(spreadsheet).sheet1
print 'Spreadsheet is ready.'
print "Decellularization logging will begin shortly. To exit, press
'Ctrl+C'\n"

#While loop to read voltages across LDRs and write to the log file
while True:
#Run the read() function created earlier to write voltages to respective
variables
volts1 = read1()
volts2 = read2()
volts3 = read3()
volts4 = read4()
#Write to the chosen spreadsheet with a timestamp and voltages from the LDRs
try:
values = [datetime.datetime.now(), volts1, volts2, volts3, volts4]
worksheet.append_row(values)
except:
print "Unable to append data."
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sys.exit()
#Print values to the CLI
print datetime.datetime.now(), volts1, volts2, volts3, volts4
#Time delay before next loop iteration (in seconds)
time.sleep(300)
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